Intermittent therapy in the palliative treatment of metastatic colorectal cancer

ISSN： 1758-194X

Source： Colorectal Cancer, Vol.2, Iss.3, 2013-06, pp. : 219-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco Fornarini Giuseppe

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

Recent Advances in the Systemic Therapy of Metastatic Colorectal Cancer

By Jefford Michael Zalcberg John

American Journal of Cancer, Vol. 4, Iss. 1, 2005-01 ,pp. : 15-34

Adis International

Access to resources Recommend Favorite

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

By Sørbye Halfdan Berglund Åke Tveit Kjell Magne Øgreid Dagfinn Wanderås Eva Hoff Wentzel-Larsen Tore Dahl Olav Glimelius Bengt

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 982-988

Informa Healthcare

Access to resources Recommend Favorite

Palliative chemotherapy in elderly patients with metastatic colorectal cancer: Do we know how it should be used?

By Sorbye Halfdan

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 819-821

Informa Healthcare

Access to resources Recommend Favorite

How I Treat Metastatic Colorectal Cancer: Incorporating Regorafenib into Therapy

By Scheithauer Werner Ychou Marc

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 11-18

Optimal Clinical Ltd

Access to resources Recommend Favorite